Researchers at Stanford Medicine have identified the biological steps that explain how mRNA-based COVID-19 vaccines can, in rare cases, lead…
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with…
mRNA vaccines developed against the spike glycoprotein of severe acute respiratory syndrome type 2 coronavirus (SARS-CoV-2), displayed remarkable efficiency in…